
Pharmaust Ltd
ASX:PAA

Intrinsic Value
The intrinsic value of one
PAA
stock under the Base Case scenario is
0.012
AUD.
Compared to the current market price of 0.165 AUD,
Pharmaust Ltd
is
Overvalued by 93%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Pharmaust Ltd
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Pharmaust Ltd
Balance Sheet Decomposition
Pharmaust Ltd
Current Assets | 11.1m |
Cash & Short-Term Investments | 9.7m |
Receivables | 18.5k |
Other Current Assets | 1.4m |
Free Cash Flow Analysis
Pharmaust Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
Pharmaust Ltd
Revenue
|
866.2k
AUD
|
Operating Expenses
|
-6.7m
AUD
|
Operating Income
|
-5.8m
AUD
|
Other Expenses
|
-1.9m
AUD
|
Net Income
|
-7.7m
AUD
|
PAA Profitability Score
Profitability Due Diligence
Pharmaust Ltd's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

Score
Pharmaust Ltd's profitability score is 13/100. The higher the profitability score, the more profitable the company is.
PAA Solvency Score
Solvency Due Diligence
Pharmaust Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Score
Pharmaust Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PAA Price Targets Summary
Pharmaust Ltd
Dividends
Current shareholder yield for PAA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PAA
stock under the Base Case scenario is
0.012
AUD.
Compared to the current market price of 0.165 AUD,
Pharmaust Ltd
is
Overvalued by 93%.